Sustainable Growth Advisers LP reduced its stake in STERIS plc (NYSE:STE) by 28.8% in the fourth quarter, now holding 758,684 shares valued at over $192 million. Other institutional investors also adjusted their positions, and a director recently sold 3,098 shares. STERIS stock opened at $210.80, with analysts giving it a "Moderate Buy" rating and a consensus target price of $278.00.

Norges Bank has acquired a significant new position in Tapestry, Inc. (NYSE:TPR) during the fourth quarter, purchasing 2,702,899 shares valued at approximately $345.35 million. This investment makes Norges Bank a substantial holder of Tapestry stock, owning 1.34% of the luxury accessories retailer. Other hedge funds have also adjusted their stakes, and the article details recent financial performance, dividends, insider trading, and analyst ratings for Tapestry.

MUFG Securities EMEA plc significantly increased its stake in Diamondback Energy, Inc. (NASDAQ:FANG) by 514.5% in the fourth quarter of 2025, holding 22,135 shares valued at $3.33 million. Other institutional investors also added to their positions, contributing to hedge funds and institutional investors owning 90.01% of the company's stock. Diamondback Energy showed strong fundamentals, exceeding Q1 earnings and revenue estimates, raising its dividend, and receiving a "Moderate Buy" rating from analysts with an average target price of $223.26.

Mawer Investment Management Ltd. significantly increased its stake in Wells Fargo & Company (NYSE:WFC) by 177.7% in the fourth quarter, now holding over 4.8 million shares valued at approximately $454 million. This makes Wells Fargo the 14th largest holding within Mawer Investment Management's portfolio. Other institutional investors also adjusted their positions in Wells Fargo, as the company reported a recent quarterly dividend and analysts provided updated ratings and price targets.

Norges Bank has acquired a significant new stake in General Mills, Inc. (NYSE:GIS), purchasing over 7.7 million shares valued at approximately $361.5 million in the fourth quarter, representing 1.46% of the company. Other institutional investors also adjusted their positions in GIS, as the company faces mixed analyst ratings with a consensus "Reduce" rating and a target price of $41.78. General Mills recently reported quarterly earnings that missed analyst estimates and experienced insider selling by two executives.

Sustainable Growth Advisers LP has reduced its stake in W.W. Grainger, Inc. (GWW) by 8.6% in the fourth quarter, selling 21,729 shares. Despite this reduction, W.W. Grainger remains a significant holding for the firm, accounting for 1.6% of its portfolio. Several other institutional investors, such as Norges Bank and Northwestern Mutual Wealth Management Co., have recently increased their positions in GWW, while company insiders have sold shares.

MUFG Securities EMEA plc significantly increased its stake in Johnson Controls International plc (NYSE:JCI) during the fourth quarter, doubling its holding to 25,054 shares valued at approximately $3.0 million. Other institutional investors also raised their positions, contributing to high institutional ownership of 90.05%. Analysts currently hold a "Hold" rating on JCI with an average target price of $147.63, with some firms recently increasing their price targets.

Mawer Investment Management Ltd. reduced its stake in American Electric Power Company, Inc. (NASDAQ:AEP) by 5.6% in the fourth quarter, selling 58,371 shares and retaining 976,788 shares valued at $112.6 million. Despite this sale, analyst sentiment for AEP remains positive, with a "Moderate Buy" consensus rating and an average target price of $141.10, supported by the company's solid quarterly earnings and a declared quarterly dividend of $0.95 per share. The company reported strong Q1 earnings, beating both EPS and revenue estimates.

Moderna's personalized cancer vaccine, intismeran autogene, combined with Merck’s Keytruda, substantially reduced recurrence or death risk in advanced melanoma patients over five years. Presented at ASCO, these Phase 2b KEYNOTE-942 trial results showed a 49% reduction in recurrence or death and a 53% boost in overall survival, instilling confidence for upcoming Phase 3 data in 2026. This regimen, despite some skepticism towards mRNA technology, represents a potential multi-billion-dollar market opportunity for Moderna, with expected market entry in 2027.

Several builders such as JPOrleans, Pulte, and Davidson Homes are actively developing residential projects across the Charlotte area. This new construction includes apartment complexes and single-family homes. The activity comes as Philadelphia-based Belgravia Management is converting an uptown office building into a mixed-use development with apartments and ground-floor retail.